Stephanie Born's Expertise includes developing and executing strategies for the non-clinical development of pharmaceuticals in the neuroscience and anti-infective areas. She has Extensive experience in the preparation of regulatory documents for US and ex-US filings ranging in complexity from those required to support early clinical trials through registration.